UROY (UROY) Stock Price & Analysis
UROY (UROY) fell 3.81% to USD 3.03 as of June 10, 2026 at 02:00 UTC, according to Nexqual real-time market data.
UROY last closed at USD 3.15; the session ranged USD 2.93–3.22 on volume of 2,837,337 shares. Market capitalization is $444.18M, with a 52-week range of USD 2.2–5.52 (NCM). Source: Nexqual, June 10, 2026 at 02:00 UTC.
Key Statistics (as of June 10, 2026 at 02:00 UTC)
| Price | USD 3.03 |
|---|---|
| Change | ▼ 3.81% (down) |
| Previous Close | USD 3.15 |
| Open | USD 3.19 |
| Day Range | USD 2.93 – 3.22 |
| 52-Week Range | USD 2.2 – 5.52 |
| Volume | 2,837,337 shares |
| Market Cap | $444.18M |
| Exchange | NCM |
Technical Analysis (UROY)
Nexqual's technical model rates UROY "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:00 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.19 (neutral) |
| vs SMA50 | Below (USD 3.68) |
| MACD | -0.14 (negative) |
Analyst Ratings (UROY)
Wall Street analysts rate UROY "None" based on 1 analysts, with a mean price target of USD 4.42 (range USD 4.42–4.42), per Nexqual as of June 10, 2026 at 02:00 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 4.42 |
| High Target | USD 4.42 |
| Low Target | USD 4.42 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (UROY)
| Next Earnings Date | 2026-03-10 |
|---|---|
| EPS Estimate | USD -0.01 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-01-31 | USD 0.01 vs est -0.01 ▲ beat |
| 2025-10-31 | USD 0.02 vs est -0.01 ▲ beat |
| 2025-07-31 | USD 0.01 vs est -0.01 ▲ beat |
| 2025-04-30 | USD -0.01 vs est -0.01 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:00 UTC.
Financials & Fundamentals (UROY)
| Total Revenue | $54.60M |
|---|---|
| Revenue Growth (YoY) | +416400.00% |
| Gross Margin | +19.91% |
| Operating Margin | +17.77% |
| Profit Margin | +8.03% |
| ROE | +1.29% |
| Debt / Equity | 0.04 |
| Current Ratio | 325.28 |
| Total Cash | $138.77M |
| Total Debt | $168,000 |
| Free Cash Flow | $37.97M |
Source: Nexqual, June 10, 2026 at 02:00 UTC.
Financial Health Score (UROY)
Nexqual rates UROY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:00 UTC.
| Growth | Critical — Revenue -64% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Strong — $139M cash, no debt |
| Cash Flow | Strong — FCF $38M, 245% margin |
| Efficiency | Weak — ROE 1%, ROA 0.4% |
Ownership (UROY)
| Insider Ownership | +14.37% |
|---|---|
| Institutional Ownership | +40.00% |
| Shares Outstanding | 146.59M |
| Float | 125.28M |
Source: Nexqual, June 10, 2026 at 02:00 UTC.
Leadership (UROY)
UROY is led by Scott Eric Melbye (age 63), CEO, President & Director, per Nexqual as of June 10, 2026 at 02:00 UTC.
| CEO, President & Director | Scott Eric Melbye (age 63) |
|---|---|
| Chief Financial Officer | Andrew Marshall BA(Hons), C.A., C.F.A. (age 45) |
Major Backers & Investors (UROY)
Notable institutional backers of UROY include SPROTT FUNDS TRUST-SPROTT URANIUM MINERS ETF, Mirae Asset Global ETFs Holdings Ltd., GLOBAL X FUNDS-Global X Uranium ETF, according to Nexqual as of June 10, 2026 at 02:00 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SPROTT FUNDS TRUST-SPROTT URANIUM MINERS ETF | 6.32% |
| Mirae Asset Global ETFs Holdings Ltd. | 6.07% |
| GLOBAL X FUNDS-Global X Uranium ETF | 5.26% |
| Alps Advisors Inc. | 2.85% |
| CWA Asset Management Group, LLC | 2.75% |
| CenterBook Partners LP | 2.41% |
| Morgan Stanley | 2.11% |
| Accordant Advisory Group Inc | 1.71% |
Source: Nexqual, June 10, 2026 at 02:00 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NXE | Nexgen Energy Ltd. | USD 9.93 | ▼ 3.4% |
| URG | Ur Energy Inc | USD 1.54 | ▼ 4.94% |
| GROY | Gold Royalty Corp. | USD 2.84 | ▲ 0.35% |
| SRUUF | Sprott Physical Uranium Trust | USD 18.45 | ▼ 2.54% |
| UEC | Uranium Energy Corp. | USD 10.65 | ▼ 15.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:00 UTC. This page is informational and not investment advice.